Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
BMC Biotechnology|April 30, 2010
Detection of tmRNA molecules on microarrays at low temperatures using helper oligonucleotidesLauris Kaplinski, Ott Scheler, Sven Parkel, et al.BMC Biotechnology|May 19, 2009
Fluorescent labeling of NASBA amplified tmRNA molecules for microarray applicationsOtt Scheler, Barry Glynn, Sven Parkel, et al.Frontiers in Genetics|November 25, 2022
The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021Laura Roht, Mikk Tooming, Kadri Rekker, et al.BMC Biotechnology|March 2, 2011
Detection of NASBA amplified bacterial tmRNA molecules on SLICSel designed microarray probesOtt Scheler, Lauris Kaplinski, Barry Glynn, et al.Nature Communications|March 11, 2018
Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's diseaseAman P Mann, Pablo Scodeller, Sazid Hussain, et al.BMJ Open|November 17, 2025
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiformeJohannes Pärtel Truusalu, Kersti Oselin, Jana Lass, et al.Nanoscale|July 12, 2017
Ratiometric in vivo auditioning of targeted silver nanoparticlesKadri Toome, Anne-Mari A Willmore, Päärn Paiste, et al.Nature Communications|November 11, 2017
Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's diseaseAman P Mann, Pablo Scodeller, Sazid Hussain, et al.Nanoscale|December 10, 2015
Targeted silver nanoparticles for ratiometric cell phenotypingAnne-Mari A Willmore, Lorena Simón-Gracia, Kadri Toome, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 1, 2019
Peptide-guided nanoparticles for glioblastoma targetingPille Säälik, Prakash Lingasamy, Kadri Toome, et al.Pageof 2